Balaxi Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

41.59

54.72

38.60

62.69

43.36

Operating profit

4.68

7.76

6.83

10.23

10.03

Interest

0.62

0.22

0.04

0.02

-

Gross profit

5.34

12.62

8.31

11.44

12.02

EPS (Rs)

0.73

1.86

1.20

1.69

1.79

Other income

1.28

5.08

1.52

1.22

1.99

Stock adjustment

-

-

-

-

-

Raw material

32.76

42.11

27.92

49.00

31.52

Power and fuel

-

-

-

-

-

Employee expenses

2.51

2.29

1.59

1.29

0.88

Excise

-

-

-

-

-

Admin and selling expenses

1.63

2.56

2.26

2.17

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

-

-

-

-

0.93

Provisions made

-

-

-

-

-

Depreciation

0.26

0.16

0.16

0.09

0.04

Taxation

1.34

3.14

2.15

2.88

3.01

Net profit / loss

3.74

9.31

6.00

8.47

8.97

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.23

10.00

10.00

10.00

10.00

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

11.26

14.19

17.69

16.32

23.13

GPM (%)

12.46

21.10

20.71

17.90

26.50

NPM (%)

8.72

15.57

14.95

13.25

19.78